These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23591255)

  • 41. Effects of estrogen therapy and aerobic training on sympathetic activity and hemodynamics in healthy postmenopausal women: a double-blind randomized trial.
    Oneda B; Cardoso CG; Forjaz CL; Araújo TG; Bernardo FR; de Gusmão JL; Pinto LG; Labes E; Abrahão SB; Mion D; Fonseca AM; Tinucci T
    Menopause; 2014 Apr; 21(4):369-75. PubMed ID: 23899829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of 17β-estradiol plus drospirenone on anthropometric and biochemical measures of adiposity in menopausal women.
    Karakus M; Gelisgen R; Topcuoglu A; Guralp O; Topcuoglu D; Simsek G; Uludag S; Uzun H
    Arch Gynecol Obstet; 2012 Nov; 286(5):1233-9. PubMed ID: 22791413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Added benefits of drospirenone for compliance.
    Foidart JM
    Climacteric; 2005 Oct; 8 Suppl 3():28-34. PubMed ID: 16203653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen plus progestin treatment: effect of different progestin components on serum markers of apoptosis in healthy postmenopausal women.
    Karaflou M; Kaparos G; Rizos D; Creatsa M; Christodoulakos G; Lambrinoudaki I
    Fertil Steril; 2010 Nov; 94(6):2399-401. PubMed ID: 20493474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy.
    Lantto H; Haapalahti P; Tuomikoski P; Viitasalo M; Väänänen H; Sovijärvi AR; Ylikorkala O; Mikkola TS
    Menopause; 2012 Jan; 19(1):82-8. PubMed ID: 21934534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
    Post MS; Christella M; Thomassen LG; van der Mooren MJ; van Baal WM; Rosing J; Kenemans P; Stehouwer CD
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1116-21. PubMed ID: 12730085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low-dose estrogen and drospirenone combination: effects on glycoinsulinemic metabolism and other cardiovascular risk factors in healthy postmenopausal women.
    Villa P; Suriano R; Ricciardi L; Tagliaferri V; De Cicco S; De Franciscis P; Colacurci N; Lanzone A
    Fertil Steril; 2011 Jan; 95(1):158-63. PubMed ID: 20728082
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial.
    Davis SR; Goldstat R; Papalia MA; Shah S; Kulkarni J; Donath S; Bell RJ
    Menopause; 2006; 13(1):37-45. PubMed ID: 16607097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen replacement therapy and cognitive functions in healthy postmenopausal women: a randomized trial.
    Gorenstein C; Rennó J; Vieira Filho AH; Gianfaldoni A; Gonçalves MA; Halbe HW; Fernandes CE; Demétrio FN
    Arch Womens Ment Health; 2011 Oct; 14(5):367-73. PubMed ID: 21732218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study.
    Wiklund I; Karlberg J; Mattsson LA
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):824-30. PubMed ID: 8456888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females.
    Duka T; Tasker R; McGowan JF
    Psychopharmacology (Berl); 2000 Apr; 149(2):129-39. PubMed ID: 10805607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA; Schaefers M; Uddin A; Utian WH
    Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drospirenone plus estradiol and the risk of serious cardiovascular events in postmenopausal women.
    Dinger J; Bardenheuer K; Heinemann K
    Climacteric; 2016 Aug; 19(4):349-56. PubMed ID: 27174159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct cognitive effects of estrogen and progesterone in menopausal women.
    Berent-Spillson A; Briceno E; Pinsky A; Simmen A; Persad CC; Zubieta JK; Smith YR
    Psychoneuroendocrinology; 2015 Sep; 59():25-36. PubMed ID: 26010861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized trial on the effect of oral combined estradiol and drospirenone on glucose and insulin metabolism in healthy menopausal women with a normal oral glucose tolerance test.
    Depypere H; Dierickx A; Vandevelde F; Stanczyk F; Ottoy L; Delanghe J; Lapauw B
    Maturitas; 2020 Aug; 138():36-41. PubMed ID: 32631586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of testosterone on visuospatial function and verbal fluency in postmenopausal women: results from a functional magnetic resonance imaging pilot study.
    Davis SR; Davison SL; Gavrilescu M; Searle K; Gogos A; Rossell SL; Egan GF; Bell RJ
    Menopause; 2014 Apr; 21(4):410-4. PubMed ID: 24061050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormone replacement therapy for cognitive function in postmenopausal women.
    Hogervorst E; Yaffe K; Richards M; Huppert F
    Cochrane Database Syst Rev; 2002; (3):CD003122. PubMed ID: 12137675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.